V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16INK4a.
about
Serrated polyposis: an enigmatic model of colorectal cancer predispositionSimilar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistanceGenetics of the serrated pathway to colorectal cancerTargeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyondConcomitant BRAF and PI3K/mTOR blockade is required for effective treatment of BRAF(V600E) colorectal cancer.A genetic progression model of Braf(V600E)-induced intestinal tumorigenesis reveals targets for therapeutic intervention.Raf kinases in cancer-roles and therapeutic opportunitiesDownregulation of DLC-1 gene by promoter methylation during primary colorectal cancer progressionBRAF vs RAS oncogenes: are mutations of the same pathway equal? Differential signalling and therapeutic implicationsSerrated polyps of the large intestine: current understanding of diagnosis, pathogenesis, and clinical managementA complex secretory program orchestrated by the inflammasome controls paracrine senescence.Molecular markers identify subtypes of stage III colon cancer associated with patient outcomesHIRA orchestrates a dynamic chromatin landscape in senescence and is required for suppression of neoplasia.Senescent fibroblasts enhance early skin carcinogenic events via a paracrine MMP-PAR-1 axis.Phosphorylations of Serines 21/9 in Glycogen Synthase Kinase 3α/β Are Not Required for Cell Lineage Commitment or WNT Signaling in the Normal Mouse Intestinep21 loss blocks senescence following Apc loss and provokes tumourigenesis in the renal but not the intestinal epitheliumCharacterization of CDKN2A(p16) methylation and impact in colorectal cancer: systematic analysis using pyrosequencing.Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients.Ibuprofen inhibits colitis-induced overexpression of tumor-related Rac1bUp-regulation of c-MYC and SIRT1 expression correlates with malignant transformation in the serrated route to colorectal cancer.Serrated polyposis associated with a family history of colorectal cancer and/or polyps: The preferential location of polyps in the colon and rectum defines two molecular entitiesLoss of Cdx2 Expression in Primary Tumors and Lymph Node Metastases is Specific for Mismatch Repair-Deficiency in Colorectal CancerNanoproteomic analysis of extracellular receptor kinase-1/2 post-translational activation in microdissected human hyperplastic colon lesionsBRAFV600E cooperates with CDX2 inactivation to promote serrated colorectal tumorigenesis.Germline mutations in oncogene-induced senescence pathways are associated with multiple sessile serrated adenomas.p16(Ink4a) overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors.Serrated polyps: critical precursors to colorectal cancer.Mechanisms of aneuploidy induction by RAS and RAF oncogenesMechanisms of acquired resistance to ERK1/2 pathway inhibitors.Colorectal serrated pathway cancers and precursors.Serrated neoplasia-role in colorectal carcinogenesis and clinical implications.Langerhans cell histiocytosis is a neoplasm and consequently its recurrence is a relapse: In memory of Bob Arceci.Clinicopathological characteristics of serrated polyps as precursors to colorectal cancer: Current status and management.Senescent cells harbour features of the cancer epigenome.Sessile Serrated Adenomas: How to Detect, Characterize and Resect.TGFβ signaling directs serrated adenomas to the mesenchymal colorectal cancer subtype.Application of artificial neural networks to link genetic and environmental factors to DNA methylation in colorectal cancer.CpG island methylator phenotype in adenocarcinomas from the digestive tract: Methods, conclusions, and controversies.A role for the epidermal growth factor receptor signaling in development of intestinal serrated polyps in mice and humans
P2860
Q24623224-584C5144-CB1B-42AA-839E-5DCBAC7B4210Q26795609-F0943CDD-D170-46AF-870A-E7C13ABBAA3CQ26860993-3F5928B6-6AEA-46DF-8A9D-A6FAF79BE8CFQ27026323-AEB13B7B-2CEA-498E-BB99-7D62A5409BF0Q27852136-CFEA783D-0C7C-4A19-9F80-4884BDBDDB93Q27852431-A38D36B9-30D5-4DE5-A8ED-125100B6DA1BQ28237793-EFC8CA0F-DCF1-4734-925A-6FBBE9C34F74Q28395305-B24F61B1-782C-4A24-9088-7102B90D3C79Q28543370-6A43834F-62F6-4A6F-99C1-853E4554A91EQ34034620-4FDF9C08-7463-4D19-A53B-5092506B8DEFQ34037190-8D916830-E701-4048-8CA3-0FA595A2FC4DQ34665492-0A301426-A898-44B0-9252-95AF5C7B78CFQ34697738-4CEA6F44-C9D4-4F85-BA09-306C66F04693Q34722924-DFC4A65A-A49C-4318-A373-07AD7B5ED12EQ36048048-8E63BA63-A579-429A-84AB-E3272D332D66Q36088890-3E85E7C0-26B7-42D5-BD9F-DE3719981DC3Q36341102-D595C391-B642-4B51-B8DA-4736DA4FBBB9Q36394050-F6B682E6-17BC-4053-A280-D1EC2424BA35Q36413436-18796C92-FDE1-42FB-9148-CE0B0CBE6DB4Q36567588-E1F82FE6-D2C7-43FF-AEF4-DFB3E24AE6F2Q37031288-C343D926-F49E-47F3-AF48-88673F36491DQ37187528-B899DC20-D1EC-4957-884C-8002BE49DC9AQ37226416-BF86E936-E3AF-4767-AA27-6C800ADB28FFQ37247510-560458FE-C40A-42B2-904F-6C821806D64FQ37608879-7F98CF19-A919-4CFA-BF83-9E90A153D8CAQ37690407-84DB2B6C-04AB-4E57-B5E1-7C514B3581B5Q37836381-A7BE400C-FEFB-49E5-BA70-F7405455E436Q37930647-A834BB85-1DE4-4281-BB6E-0FDF69C978A7Q37948057-0C77E0E6-4898-4129-BF12-B83E73C285A7Q38007869-90CF4902-341D-4830-8FC0-7B3998B817F5Q38255029-D6FE2BB9-9E6E-4B2A-AB5B-A005C39FE6FEQ38473801-5DE386F8-1C98-422F-BA87-8EB276FF9A17Q38868299-CE1DD26C-B799-4AB3-9440-B6B036D8F35BQ38885314-E5B653C7-A9D2-41A9-9FB0-E1863C7B22AAQ39056256-C45016B4-6BAA-492F-9770-4377AA99B352Q39298941-226D31CA-4C56-4931-AC6C-6189E461F218Q39739202-0BA94FF4-E91A-4ADE-9404-4E165139B52AQ40975165-1827FF22-E6D6-4517-B646-D9C231C7AA3FQ42316699-2447344D-C6DB-435A-A9B3-88C158B898FAQ42322139-BF710AFC-AAF2-45FB-BE94-7B98C6A2443D
P2860
V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16INK4a.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
V600EBraf induces gastrointest ...... d CpG methylation of p16INK4a.
@en
V600EBraf induces gastrointest ...... d CpG methylation of p16INK4a.
@nl
type
label
V600EBraf induces gastrointest ...... d CpG methylation of p16INK4a.
@en
V600EBraf induces gastrointest ...... d CpG methylation of p16INK4a.
@nl
prefLabel
V600EBraf induces gastrointest ...... d CpG methylation of p16INK4a.
@en
V600EBraf induces gastrointest ...... d CpG methylation of p16INK4a.
@nl
P2093
P2860
P50
P356
P1476
V600EBraf induces gastrointest ...... d CpG methylation of p16INK4a.
@en
P2093
Bipin Patel
Doug J Winton
Kimberley R Snell
Linda A S Carragher
Susan M Giblett
Victoria S S Aldridge
P2860
P304
P356
10.1002/EMMM.201000099
P577
2010-11-01T00:00:00Z